Jianqin Xie

Jianqin Xie

Auto-generated profile, based on publicly available information

Jianqin Xie

Department of Anesthesiology, The Second Hospital & Clinical Medical School, Lanzhou University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
ZFZhijun Feng
Zhijun Feng
LGLina Gao
Lina Gao
YLYapeng Lu
Yapeng Lu
XHXiaodong He
Xiaodong He
JXJianqin Xie
Jianqin Xie
The role of cathepsin K (CTSK) expression in the pathogenesis and progression of gastric cancer (GC) remains unclear. Hence, the primary objective of this study is to elucidate the precise expression and biological role of CTSK in GC by employing a combination of bioinformatics analysis and in vitro experiments. Our findings indicated a significant upregulation of CTSK in GC. The bioinformatics analysis revealed that GC patients with a high level of CTSK expression exhibited enrichment of hallmark gene sets associated with angiogenesis, epithelial–mesenchymal transition (EMT), inflammatory response, KRAS signaling up, TNFα signaling via KFκB, IL2-STAT5 signaling, and IL6-JAK-STAT3 signaling. Additionally, these patients demonstrated elevated levels of M2-macrophage infiltration, which was also correlated with a poorer prognosis. The results of in vitro experiments provided confirmation that the over-expression of CTSK leads to an increase in the proliferative and invasive abilities of GC cells. However, further evaluation was necessary to determine the impact of CTSK on the migration capability of these cells. Our findings suggested that CTSK has the potential to facilitate the initiation and progression of GC by augmenting the invasive capacity of GC cells, engaging in tumor-associated EMT, and fostering the establishment of an immunosuppressive tumor microenvironment (TME).

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JXJian-Qin Xie
Jian-Qin Xie
YLYa-Peng Lu
Ya-Peng Lu
HSHong-Li Sun
Hong-Li Sun
LGLi-Na Gao
Li-Na Gao
PSPei-Pei Song
Pei-Pei Song
CYChongge You
Chongge You
Ischemic stroke (IS) greatly threatens human health resulting in high mortality and substantial loss of function. Recent studies have shown that the outcome of IS has sex specific, but its mechanism is still unclear. This study is aimed at identifying the sexually dimorphic to peripheral immune response in IS progression, predicting potential prognostic biomarkers that can lead to sex‐specific outcome, and revealing potential treatment targets. Gene expression dataset GSE37587, including 68 peripheral whole blood samples which were collected within 24 hours from known onset of symptom and again at 24‐48 hours after onset (20 women and 14 men), was downloaded from the Gene Expression Omnibus (GEO) datasets. First, using Bioconductor R package, two kinds of differentially expressed genes (DEGs) (nonsex‐specific‐ and sex‐specific‐DEGs) were screened by follow‐up (24‐48 hours) vs. baseline (24 hours). 30 nonsex‐specific DEGs (1 upregulated and 29 downregulated), 79 female‐specific DEGs (25 upregulated and 54 downregulated), and none of male‐specific DEGs were obtained finally. Second, bioinformatics analysis of female‐specific DEGs was performed. Gene Ontology (GO) functional annotation analysis shows that DEGs were mainly enriched in translational initiation, cytosolic ribosome, and structural constituent of ribosome. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis shows that the top 6 enrichment pathways are ribosome, nuclear factor‐­kappa B (NF‐kappa B) signaling pathway, apoptosis, mineral absorption, nonalcoholic fatty liver disease, and pertussis. Three functional modules were clustered in the protein–protein interaction (PPI) network of DEGs. The top 10 key genes of the PPI network constructed were selected, including RPS14, RPS15A, RPS24, FAU, RPL27, RPL31, RPL34, RPL35A, RSL24D1, and EEF1B2. Sex difference of ribosome in stroke‐induced peripheral immunosuppression may be the potential mechanism of sex disparities in outcome after IS, and women are more likely to have stroke‐induced immunosuppression. RPS14, RPS15A, RPS24, FAU, RPL27, RPL31, RPL34, RPL35A, RSL24D1, and EEF1B2 may be novel prognostic biomarkers and potential therapeutic targets for IS.

22 September 2021 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
WLWei Li
Wei Li
PSPeipei Song
Peipei Song
MZMengyuan Zhao
Mengyuan Zhao
LGLina Gao
Lina Gao
JXJianqin Xie
Jianqin Xie
CYChongge You
Chongge You
Previous studies have indicated the important role of block of proliferation 1 (BOP1) in the progression of several malignant tumors; no comprehensive pan-cancer analysis of BOP1 has been performed. Here, we aim to systematically identify the expression, prognostic value, and potential immunological functions of BOP1 in 33 malignancies. We obtained the gene expression data and clinical information from multiple public databases to assess the expression level and prognostic value of BOP1 in 33 cancers. We also analyzed the relationship between BOP1 expression and DNA methylation, tumor microenvironment (TME), microsatellite instability (MSI), tumor mutational burden (TMB), and immune checkpoints. Moreover, we conducted gene set enrichment analysis (GSEA) to investigate the biological function and signal transduction pathways of BOP1 in different types of tumors. Finally, we validated the expression of BOP1 in lung cancer cell line and detected the influence of BOP1 on lung cancer cell migration and the expression of epithelial-mesenchymal transition- (EMT-) related genes. Collectively, our findings elucidated that BOP1 has the potential to be a promising molecular prognostic biomarker for predicting poor survival in various malignant tumors, as well as a cancer-promoting gene involved in tumorigenesis and tumor immunity.

16 September 2025 in Phytomedicine
Verified
Journal Article
Closed access
TZTing Zheng
Ting Zheng
TJTaotao Jiang
Taotao Jiang
YCYufeng Chen
Yufeng Chen
JXJianqing Xie
Jianqing Xie
WYWeiyuan Yu
Weiyuan Yu
MWManxia Wang
Manxia Wang

5 October 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LGLi Gao
Li Gao
ZLZixuan Liang
Zixuan Liang
JXJianqin Xie
Jianqin Xie
Large-vessel recanalization is essential in acute ischemic stroke, but it does not guarantee microvascular reperfusion. Endothelial responses may contribute to persistent tissue hypoperfusion through leukocyte trafficking and immunothrombosis. Many of these responses may begin during ischemia and may continue or intensify when blood flow returns. We therefore use postischemic or ischemia/reperfusion-associated terminology unless experiments isolate the contribution of reperfusion. We propose that endothelial immune reprogramming requires a coordinated molecular program, localization to a defined vascular segment and time, and a corresponding change in immune-regulatory function. An isolated increase in an adhesion molecule or circulating biomarker indicates activation or injury but cannot identify such a state. Barrier/stress, adhesive/chemotactic, and prothrombotic responses overlap. Experimental studies implicate endothelial signaling, leukocyte arrest, and platelet interactions with neutrophil extracellular traps, but have not established a common sequence of endothelial states. Human evidence comes mainly from circulating biomarkers, thrombectomy thrombi, post-mortem tissue, and perfusion imaging. The available findings have yet to link a defined cerebral endothelial state to downstream perfusion and clinical outcome in the same patients. Prospective studies should combine serial vascular biomarkers, repeated perfusion imaging, and longitudinal follow-up, with endothelial-enriched molecular profiling when tissue is available. Therapeutic studies should test whether modifying a reversible endothelial program relieves no-reflow while preserving later immune resolution and vascular repair. These approaches remain investigational.